Concepedia

D. B. ULISS

DB

11

Publications

248

Citations

11

H-Index

1970

Active since

Affiliations

Sheehan Medical (United States)(Current)

D. B. ULISS is an author at Sheehan Medical (United States) specializing in natural sciences, drug discovery, and medicine.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryNatural SciencesCannabinoid PharmacologyCannabisOrganic ChemistryChemistryCannabinoids

Publications per year

1970–1991

11

Publications

11

Stereospecific intramolecular epoxide cleavage by phenolate anion. Synthesis of novel and biologically active cannabinoids

D. B. ULISS, Raj K. Razdan, H. C. DALZELL · Journal of the American Chemical Society · 1974 · 43 citations

Bioorganic Chemistry, Altmetric Attention Score, Secondary Metabolite +16

Synthesis of racemic and optically active .DELTA.9-tetrahydrocannabinol (THC) metabolites

Craig Siegel, Patrick M. Gordon, D. B. ULISS et al. · The Journal of Organic Chemistry · 1991 · 34 citations

Cannabis Use, Therapeutic Drug Monitoring, Natural Product Synthesis +14

Hashish. Importance of the phenolic hydroxyl group in tetrahydrocannabinols

D. B. ULISS, H. C. DALZELL, G. R. HANDRICK et al. · Journal of Medicinal Chemistry · 1975 · 30 citations

Hashish. IX. Synthesis of 7-hydroxy-.DELTA.'-tetrahydrocannabinol (THC). Important active metabolite of .DELTA.'-THC in man

Raj K. Razdan, D. B. ULISS, H. C. DALZELL · Journal of the American Chemical Society · 1973 · 24 citations

Cannabis Use, Important Active Metabolite, Natural Product Synthesis +13

Hashish. 26. Factors influencing double-bond stability in cannabinoids

H. C. DALZELL, D. B. ULISS, G. R. HANDRICK et al. · The Journal of Organic Chemistry · 1981 · 24 citations

Altmetric Attention Score, Organic Chemistry, Chemistry +18

Rows per page

1–5 of 11